These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26021280)

  • 1. Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium.
    Kinaan M; Ding H; Triggle CR
    Med Princ Pract; 2015; 24(5):401-15. PubMed ID: 26021280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent.
    Chung MM; Chen YL; Pei D; Cheng YC; Sun B; Nicol CJ; Yen CH; Chen HM; Liang YJ; Chiang MC
    Biochim Biophys Acta; 2015 May; 1852(5):720-31. PubMed ID: 25595658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
    Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
    Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
    Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
    J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
    Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target.
    Boyle JG; Salt IP; McKay GA
    Diabet Med; 2010 Oct; 27(10):1097-106. PubMed ID: 20854376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
    Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway.
    Hsu SK; Cheng KC; Mgbeahuruike MO; Lin YH; Wu CY; Wang HD; Yen CH; Chiu CC; Sheu SJ
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
    Dutta S; Shah RB; Singhal S; Dutta SB; Bansal S; Sinha S; Haque M
    Drug Des Devel Ther; 2023; 17():1907-1932. PubMed ID: 37397787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
    Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
    Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal on metformin.
    Adak T; Samadi A; Ünal AZ; Sabuncuoğlu S
    Regul Toxicol Pharmacol; 2018 Feb; 92():324-332. PubMed ID: 29291990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area.
    Tulipano G
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.